Richard B. Gearry
Researcher Next ID · RN-022582
Researcher · Biochemistry, Genetics and Molecular Biology
Wellington, New Zealand
- Works count
- 617
- Citation count
- 30,795
- H-index
- 74
- i10-index
- 261
Research interests
Publications
Global evolution of inflammatory bowel disease across epidemiologic stages
Nature · 2025 · https://doi.org/10.1038/s41586-025-08940-0
Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries
Nature Genetics · 2023 · https://doi.org/10.1038/s41588-023-01384-0
Global Hospitalization Trends for Crohn’s Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses
Clinical Gastroenterology and Hepatology · 2022 · https://doi.org/10.1016/j.cgh.2022.06.030
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry
Gastroenterology · 2020 · https://doi.org/10.1053/j.gastro.2020.05.032
Effect of IBD medications on COVID-19 outcomes: results from an international registry
Gut · 2020 · https://doi.org/10.1136/gutjnl-2020-322539
Management of Patients With Crohn’s Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting
Gastroenterology · 2020 · https://doi.org/10.1053/j.gastro.2020.04.002
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes
Nature Communications · 2018 · https://doi.org/10.1038/s41467-018-04365-8
Sex-Based Differences in Incidence of Inflammatory Bowel Diseases—Pooled Analysis of Population-Based Studies From Western Countries
Gastroenterology · 2018 · https://doi.org/10.1053/j.gastro.2018.06.043
Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease
Nature Genetics · 2017 · 10.1038/ng.3755
Development of an index to define overall disease severity in IBD
Gut · 2016 · https://doi.org/10.1136/gutjnl-2016-312648
Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection
Gastroenterology · 2016 · 10.1053/j.gastro.2016.04.002
World Gastroenterology Organisation Global Guidelines Inflammatory Bowel Disease
Journal of Clinical Gastroenterology · 2016 · https://doi.org/10.1097/mcg.0000000000000660
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection
Gastroenterology · 2016 · https://doi.org/10.1053/j.gastro.2016.02.072
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
The American Journal of Gastroenterology · 2015 · https://doi.org/10.1038/ajg.2015.233
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study
The Lancet · 2015 · https://doi.org/10.1016/s0140-6736(15)00465-1
Measurement of Fecal Calprotectin Improves Monitoring and Detection of Recurrence of Crohn's Disease After Surgery
Gastroenterology · 2015 · 10.1053/j.gastro.2015.01.026
Crohn's disease management after intestinal resection: a randomised trial
The Lancet · 2014 · 10.1016/s0140-6736(14)61908-5
Antibiotics Associated With Increased Risk of New-Onset Crohn’s Disease But Not Ulcerative Colitis: A Meta-Analysis
The American Journal of Gastroenterology · 2014 · 10.1038/ajg.2014.246
The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study
International Journal of Clinical Practice · 2013 · 10.1111/ijcp.12128
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
Nature · 2012 · https://doi.org/10.1038/nature11582
The Spectrum of Perianal Crohn’s Disease in a Population-Based Cohort
Diseases of the Colon & Rectum · 2012 · 10.1097/dcr.0b013e31825228b0
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47
Nature Genetics · 2011 · https://doi.org/10.1038/ng.764
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
Nature Genetics · 2010 · https://doi.org/10.1038/ng.717
Dietary poorly absorbed, short‐chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon
Alimentary Pharmacology & Therapeutics · 2010 · 10.1111/j.1365-2036.2010.04237.x
World Gastroenterology Organization Practice Guidelines for the Diagnosis and Management of IBD in 2010
Inflammatory Bowel Diseases · 2009 · 10.1002/ibd.21048
Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease—a pilot study
Journal of Crohn s and Colitis · 2008 · 10.1016/j.crohns.2008.09.004
High incidence of Crohnʼs disease in Canterbury, New Zealand: Results of an epidemiologic study
Inflammatory Bowel Diseases · 2006 · 10.1097/01.mib.0000231572.88806.b9
Current projects
No projects listed.